Sotera Health (NASDAQ:SHC) Sees Unusually-High Trading Volume - Should You Buy?

Sotera Health (NASDAQ:SHC - Get Free Report) shares saw unusually-strong trading volume on Tuesday . Approximately 1,561,190 shares changed hands during trading, an increase of 33% from the previous session's volume of 1,171,206 shares.The stock last traded at $11.36 and had previously closed at $11.66.

Analyst Upgrades and Downgrades

SHC has been the topic of a number of recent analyst reports. Barclays decreased their price objective on Sotera Health from $17.00 to $16.00 and set an "overweight" rating on the stock in a report on Friday, February 28th. The Goldman Sachs Group initiated coverage on Sotera Health in a research report on Friday, December 6th. They issued a "neutral" rating and a $14.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat, Sotera Health presently has an average rating of "Moderate Buy" and a consensus target price of $16.00.

Sotera Health Stock Performance

The company has a market capitalization of $2.94 billion, a price-to-earnings ratio of 41.53 and a beta of 1.92. The stock's fifty day simple moving average is $12.67 and its 200-day simple moving average is $13.87. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91.

Hedge Funds Weigh In On Sotera Health

Several hedge funds and other institutional investors have recently made changes to their positions in SHC. Geode Capital Management LLC raised its holdings in Sotera Health by 19.4% in the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company's stock valued at $46,026,000 after acquiring an additional 447,186 shares in the last quarter. Neo Ivy Capital Management acquired a new stake in shares of Sotera Health in the 3rd quarter valued at $720,000. Barclays PLC raised its holdings in shares of Sotera Health by 169.8% in the 3rd quarter. Barclays PLC now owns 473,597 shares of the company's stock valued at $7,909,000 after purchasing an additional 298,085 shares in the last quarter. SG Americas Securities LLC lifted its position in shares of Sotera Health by 271.6% during the 4th quarter. SG Americas Securities LLC now owns 36,364 shares of the company's stock worth $497,000 after purchasing an additional 26,577 shares during the last quarter. Finally, KBC Group NV grew its stake in shares of Sotera Health by 4,094.6% during the fourth quarter. KBC Group NV now owns 186,365 shares of the company's stock worth $2,549,000 after purchasing an additional 181,922 shares in the last quarter. Hedge funds and other institutional investors own 91.03% of the company's stock.

Remove Ads

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.